InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | 2026-05-11 | LAVIOLETTE PAUL A | Director & Chief Executive Officer | Purchase | 15.0K | $19.69 | $295K | 15.0K | View ↗ | |
| 2026-05-11 | 2026-05-11 | DUGGAN ROBERT W | Director | Purchase | 660.2K | $19.69 | $13.00M | 48.21M | View ↗ | |
| 2026-02-18 | 2026-02-23 | Danahy Kevin Patrick | Chief Commercial Officer | Sale | 5,000 | $23.64 | $118K | 43.3K | View ↗ | |
| 2026-02-17 | 2026-02-17 | Danahy Kevin Patrick | Chief Commercial Officer | Sale | 20.0K | $23.63 | $473K | 43.3K | View ↗ | |
| 2026-02-13 | 2026-02-17 | Danahy Kevin Patrick | Chief Commercial Officer | Sale | 20.0K | $23.53 | $471K | 43.3K | View ↗ |
No annual data found.
Pulse Bio rises after over $13M insider buying
ATM Equity Purchases by Pulse Biosciences’ Co-Chairmen Total Approximately $13.3 Million
Is Pulse Biosciences (PLSE) Quietly Redefining Its Core Identity Around Atrial Fibrillation?
Pulse Biosciences Q1 Earnings Call Highlights